Company News
Marksans Pharma Acquires Netherlands' QliniQ for €7.5M
Marksans Pharma announced the acquisition of 100% of Netherlands-based pharmaceutical distributor QliniQ B.V. for a cash consideration of €7.5 million.
QliniQ reported FY2025 revenue of €9.35 million
